DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Acceleron Pharma Inc. (XLRN)
« Back to company indexXLRN Chatter Timeline
Stock Ticker for XLRN
Most Active Tweeters for XLRN
| User | Tweets |
|---|---|
| @thefinreviewer | 16 |
| @bibeypost_stock | 5 |
| @bulletin_en | 5 |
| @reurope_stock | 4 |
| @FinZTribune | 3 |
Recent Tweets for XLRN
 |
@UlmHi Reviewing Arcus Biosciences Inc. $XLRN's results https://t.co/eVcv43JfR4 March 21st 2019, 8:03pm |
 |
@ThisLincolnian Acceleron Pharma Inc $XLRN Expected to Post Quarterly Sales of $3.79 Million https://t.co/ggIMBjrKMt March 21st 2019, 7:03pm |
 |
@bibeypost_stock Institutional Investors Lead Shift in Acceleron Pharma Inc $XLRN Sentiment https://t.co/t0FUMhlaoi March 21st 2019, 12:03pm |
 |
@bulletin_en Acceleron Pharma Inc. $XLRN Ratings Summary on Mar 21, 2019 https://t.co/B8zxgHHE5T March 21st 2019, 11:03am |
|
@UlmHi Aerpio Pharmaceuticals Inc. $XLRN Contrasting side by side https://t.co/BIfvdZEP1C March 21st 2019, 12:03am |
 |
@thefinreviewer Reviewing Liquidia Technologies Inc. $XLRN's results https://t.co/ujIaoVe8vq March 20th 2019, 5:03pm |
|
@thefinreviewer Contrasting of ASLAN Pharmaceuticals Limited $XLRN https://t.co/HZpKMVhkbU March 20th 2019, 1:03pm |
|
@bibeypost_stock Are Analysts Bullish Acceleron Pharma Inc. $XLRN After Last Week? https://t.co/ItyHl4sR2u March 20th 2019, 9:03am |
|
@thefinreviewer Comparing of BioCryst Pharmaceuticals Inc. $XLRN https://t.co/7q1yBk2E8R March 20th 2019, 1:03am |
 |
@mmahotstuff1 What Will Happen to Acceleron Pharma Inc $XLRN Next? The Stock Has Decline in Shorts https://t.co/ceRYMnvNFM March 19th 2019, 5:03pm |
 |
@whatsonthorold2 It Seems Acceleron Pharma Inc $XLRN Will Go Up. Just Reported Less Shorted Shares https://t.co/EkqQjFs76m March 19th 2019, 5:03pm |
 |
@reurope_stock Acceleron Pharma Inc $XLRN's Stock Is Buy After Less Market Selling https://t.co/H2Z85cgVOR March 19th 2019, 5:03pm |
|
@whatsonthorold2 Sectoral Asset Management INC Lowered Holding in Acceleron Pharma $XLRN by $3.74 Million https://t.co/YmV2jGFH2k March 19th 2019, 5:03pm |
|
@reurope_stock Sectoral Asset Management INC Trimmed Acceleron Pharma $XLRN Holding by $3.74 Million https://t.co/7V2HtJ4qbo March 19th 2019, 5:03pm |
 |
@dakotafinancial Acceleron Pharma Inc $XLRN Expected to Post Earnings of -$0.69 Per Share https://t.co/mCftXhuTTl March 19th 2019, 12:03pm |
 |
@macondailynews Acceleron Pharma Inc $XLRN Expected to Post Earnings of -$0.69 Per Share https://t.co/CXKQyzuL8G March 19th 2019, 12:03pm |
 |
@WatchlistN $3.79 Million in Sales Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/OoeWEHUnVB March 19th 2019, 12:03pm |
|
@bulletin_en As Acceleron Pharma INC $XLRN Shares Declined, Great Point Partners LLC Increased Stake by $5.11 Million https://t.co/IwjyFxoyxd March 19th 2019, 8:03am |
 |
@FinZTribune As Acceleron Pharma INC $XLRN Shares Declined, Great Point Partners LLC Increased Its Stake by $5.11 Million https://t.co/AEZPAh6FAH March 19th 2019, 8:03am |
|
@reurope_stock As Entegris $ENTG Stock Price Rose, Shareholder Cooke & Bieler LP Boosted Position; Acceleron Pharma $XLRN Holder T… https://t.co/Jrd09PRTsg March 19th 2019, 6:03am |
 |
@AmericanBanking Acceleron Pharma $XLRN & ABLYNX NV/ADR $ABLX Head-To-Head Analysis https://t.co/N71UexLYfK #stocks March 18th 2019, 10:03am |
|
@dakotafinancial Acceleron Pharma $XLRN & ABLYNX NV/ADR $ABLX Head-To-Head Analysis https://t.co/vOJR3dTzRL March 18th 2019, 10:03am |
|
@ThisLincolnian -$0.69 EPS Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/hgjF89HHOp March 17th 2019, 2:03pm |
|
@bulletin_en Acceleron Pharma Inc. $XLRN Is Forming Double Top Chart Pattern at $47.13 https://t.co/dVFzFFGHuN March 17th 2019, 9:03am |
|
@FinZTribune Acceleron Pharma Inc. $XLRN Trades at $47.13 Forming Double Top Pattern https://t.co/NV8CNlp8rF March 17th 2019, 9:03am |
 |
@BlogYomi Comparison of Mersana Therapeutics Inc. $XLRN https://t.co/GunZpAxT8W March 17th 2019, 3:03am |
|
@FinZTribune Last Week Acceleron Pharma Inc. $XLRN Ratings https://t.co/3ZcfP9LxvB March 16th 2019, 1:03pm |
|
@thefinreviewer Benitec Biopharma Limited $XLRN Contrasting side by side https://t.co/0395OFBSJY March 16th 2019, 10:03am |
 |
@gtlackey $XLRN with new closing high for the move, trying to sneak out the topside... March 16th 2019, 8:03am |
 |
@dispatchtribune Acceleron Pharma $XLRN Sees Unusually-High Trading Volume https://t.co/eoYk02paOX March 15th 2019, 9:03pm |
|
@thefinreviewer Reviewing Revance Therapeutics Inc. $XLRN's results https://t.co/OwL4RLTAxd March 15th 2019, 9:03pm |
 |
@kkernttb $XLRN breakout watch https://t.co/EEEnzDDmFK March 15th 2019, 10:03am |
 |
@stocknewstimes Zacks: Brokerages Expect Acceleron Pharma Inc $XLRN Will Announce Earnings of -$0.69 Per Share https://t.co/a48z9QrreV March 15th 2019, 3:03am |
 |
@TheMarketsDaily -$0.69 EPS Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/UGLvAfyKBJ March 15th 2019, 3:03am |
|
@thefinreviewer Sierra Oncology Inc. $XLRN Contrasting side by side https://t.co/pOEQVRDPDY March 14th 2019, 9:03pm |
|
@gtlackey $XLRN at top of gap but rejections not holding, next move starting to lean higher. https://t.co/1m93jSZEE1 March 14th 2019, 6:03am |
|
@AmericanBanking Brokerages Expect Acceleron Pharma Inc $XLRN Will Announce Quarterly Sales of $3.79 Million https://t.co/1BMXpz7MLk #stocks March 14th 2019, 2:03am |
|
@dispatchtribune Brokerages Expect Acceleron Pharma Inc $XLRN Will Announce Quarterly Sales of $3.79 Million https://t.co/Uj1AWtgHQp March 14th 2019, 2:03am |
 |
@OlympiaReport $3.79 Million in Sales Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/hCTZESPO9S March 14th 2019, 2:03am |
|
@thefinreviewer Reviewing Midatech Pharma Plc $XLRN's results https://t.co/Am0xwGZNHg March 14th 2019, 1:03am |
|
@BlogYomi MacroGenics Inc. $XLRN Comparison side by side https://t.co/KgfLr54Xaz March 14th 2019, 1:03am |
|
@thefinreviewer Nightstar Therapeutics plc $XLRN Comparing side by side https://t.co/1nqXcZfJek March 14th 2019, 12:03am |
|
@mmahotstuff1 As Acceleron Pharma INC $XLRN Stock Value Declined, Great Point Partners LLC Increased Position https://t.co/c4XLjveNy6 March 13th 2019, 4:03pm |
|
@bibeypost_stock Acceleron Pharma Inc $XLRN's Stock Is Buy After Less Market Selling https://t.co/vPm3pHiHq9 March 13th 2019, 8:03am |
|
@thefinreviewer Comparing of ArQule Inc. $XLRN https://t.co/WiWTfiHOZL March 13th 2019, 2:03am |
|
@bulletin_en Mesoblast Limited $XLRN Comparison side by side https://t.co/bUtHw7Zs9V March 12th 2019, 11:03pm |
|
@thefinreviewer Reviewing Eyenovia Inc. $XLRN's results https://t.co/roMCMLlQ3l March 12th 2019, 11:03pm |
|
@mmahotstuff1 This is what analysts have to say about Acceleron Pharma Inc. $XLRN after last week. https://t.co/0GA1PzPscZ March 12th 2019, 4:03pm |
|
@AmericanBanking -$0.60 Earnings Per Share Expected for Acceleron Pharma Inc $XLRN This Quarter https://t.co/EVQMhThPNf #stocks March 12th 2019, 10:03am |
|
@bulletin_en Acceleron Pharma Inc. $XLRN Is Forming Double Top at $46.38 https://t.co/d7S82h7Ub7 March 12th 2019, 7:03am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.